Tactile Systems Technology Inc (TCMD)

Tactile Systems Technology Inc. experienced significant insider trading activity recently, characterized exclusively by divestments. Executives, including the CEO, offloaded shares following the latest earnings report. These transactions reflect a downward trend in stock performance, with the equity currently trading near the lower end of its fifty-two-week range amid consistent selling pressure from leadership.
Ticker: TCMD Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tactile Systems Technology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
BURKE WILLIAM W Non-Executive Director
Transaction date
Planned sale
Price
425.85
Quantity 21,664 +7.3%
Value US$3,218,696
King Laura G. Non-Executive Director
Transaction date
Planned sale
Price
226.73
Quantity 33,214 -5.1%
Value US$2,842,634
King Laura G. Director Non-Executive Director
Transaction date
Proposed sale
Price
377.47
Quantity 21,900
Value US$4,389,189
2.6
William W Burke board of director Non-Executive Director
Transaction date
Proposed sale
Price
36,017.33
Quantity 15,000
Value US$540,260,000
3.1
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
29.44
Quantity 10,978 -4.5%
Value US$323,243
3.1
Dodd Sheri Louise Officer; Director Executive Director
Transaction date
Proposed sale
Price
29.44
Quantity 10,978
Value US$323,243
3.2
Birkemeyer Elaine M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
24.49
Quantity 4,631 -3.4%
Value US$113,404
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
24.49
Quantity 4,631
Value US$113,404
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
28.47
Quantity 4,000
Value US$113,880
3.1
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
28.94
Quantity 10,993 -4.3%
Value US$318,144
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
28.94
Quantity 6,246 -7.0%
Value US$180,764
3.2
Birkemeyer Elaine M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
28.94
Quantity 7,701 -5.4%
Value US$222,880
3.1
Dodd Sheri Louise Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.94
Quantity 10,993
Value US$318,148
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
28.94
Quantity 7,701
Value US$222,875
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
28.94
Quantity 6,246
Value US$180,765
3.2
Birkemeyer Elaine M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
28.69
Quantity 196 -0.1%
Value US$5,623
3.2
Birkemeyer Elaine M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
28.28
Quantity 5,322 -3.6%
Value US$150,521
3.1
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
28.69
Quantity 537 -0.2%
Value US$15,406
3.1
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
28.28
Quantity 14,703 -5.4%
Value US$415,839
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
28.69
Quantity 160 -0.2%
Value US$4,590
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
28.28
Quantity 4,279 -4.6%
Value US$121,022
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
28.30
Quantity 4,439
Value US$125,610
3.1
Dodd Sheri Louise Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.30
Quantity 15,240
Value US$431,246
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
28.30
Quantity 5,518
Value US$156,143
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
28.85
Quantity 5,139 -6.6%
Value US$148,260
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
28.85
Quantity 5,139
Value US$148,260
3.1
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
12.36
Quantity 7,762 -4.3%
Value US$95,907
3.1
Dodd Sheri Louise Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.36
Quantity 7,762
Value US$95,906
3.2
Birkemeyer Elaine M. Chief Financial Officer Officer
Transaction date
Planned sale
Price
9.94
Quantity 2,921 -2.9%
Value US$29,037
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
9.94
Quantity 2,921
Value US$29,037
3.1
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
9.83
Quantity 3,149 -1.7%
Value US$30,955
2.6
BURKE WILLIAM W Non-Executive Director
Transaction date
Planned sale
Price
9.67
Quantity 3,300 -6.4%
Value US$31,911
3.1
Dodd Sheri Louise Director Non-Executive Director
Transaction date
Proposed sale
Price
9.83
Quantity 3,149
Value US$30,955
2.6
BURKE WILLIAM W Director Non-Executive Director
Transaction date
Proposed sale
Price
9.67
Quantity 3,300
Value US$31,911
0.7
Ferstler Sherri Lee Officer Officer
Transaction date
Proposed sale
Price
13.14
Quantity 2,355
Value US$30,945
3.6
REUVERS DANIEL L. Non-Executive Director
Transaction date
Planned sale
Price
14.18
Quantity 28,338 -11.7%
Value US$401,850
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
14.40
Quantity 6,468 -7.7%
Value US$93,160
3.2
Birkemeyer Elaine M. Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.51
Quantity 2,066 -2.0%
Value US$29,980
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
14.18
Quantity 28,338
Value US$401,851
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
14.40
Quantity 6,468
Value US$93,160
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
14.51
Quantity 2,066
Value US$29,980
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
14.55
Quantity 10,938
Value US$159,147
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
14.65
Quantity 4,830
Value US$70,753
0.7
Ferstler Sherri Lee Officer Officer
Transaction date
Proposed sale
Price
14.79
Quantity 2,209
Value US$32,660
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
14.70
Quantity 3,778
Value US$55,538
3.6
REUVERS DANIEL L. Non-Executive Director
Transaction date
Planned sale
Price
14.55
Quantity 10,938 -4.3%
Value US$159,147
3.2
Birkemeyer Elaine M. Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.70
Quantity 3,778 -3.5%
Value US$55,538
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
14.65
Quantity 4,830 -5.4%
Value US$70,753
0.7
Ferstler Sherri Lee Senior VP, Sales Officer
Transaction date
Sale
Price
13.07
Quantity 1,550 -3.8%
Value US$20,263
0.7
Ferstler Sherri Lee Officer Officer
Transaction date
Proposed sale
Price
13.07
Quantity 1,550
Value US$20,262
3.2
Birkemeyer Elaine M. Chief Financial Officer Officer
Transaction date
Sale
Price
13.68
Quantity 3,041 -4.7%
Value US$41,590
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
13.68
Quantity 3,041
Value US$41,590
2.6
BURKE WILLIAM W Non-Executive Director
Transaction date
Planned sale
Price
14.06
Quantity 2,500 -9.0%
Value US$35,150
2.6
BURKE WILLIAM W Director Non-Executive Director
Transaction date
Proposed sale
Price
14.06
Quantity 2,500
Value US$35,150
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
14.37
Quantity 815 -1.3%
Value US$11,713
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
14.37
Quantity 815
Value US$11,713
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
15.25
Quantity 1,396
Value US$21,289
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
15.25
Quantity 243
Value US$3,706
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Planned sale
Price
15.25
Quantity 1,396 -0.6%
Value US$21,289
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
15.25
Quantity 243 -0.4%
Value US$3,706
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Planned sale
Price
15.60
Quantity 4,689 -1.9%
Value US$73,148
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
15.58
Quantity 1,091 -1.7%
Value US$17,001
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
15.60
Quantity 4,689
Value US$73,148
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
15.58
Quantity 1,091
Value US$17,001
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
15.91
Quantity 2,015 -3.1%
Value US$32,049
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Planned sale
Price
15.81
Quantity 6,239 -2.5%
Value US$98,645
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
15.81
Quantity 6,239
Value US$98,645
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
15.91
Quantity 2,015
Value US$32,049
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
14.80
Quantity 2,249 -4.0%
Value US$33,278
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Planned sale
Price
14.85
Quantity 5,378 -2.7%
Value US$79,853
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
14.80
Quantity 2,249
Value US$33,278
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
14.85
Quantity 5,378
Value US$79,853
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Sale
Price
20.53
Quantity 1,062 -0.8%
Value US$21,808
3.6
REUVERS DANIEL L. Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.53
Quantity 1,062
Value US$21,808
2.6
BURKE WILLIAM W Non-Executive Director
Transaction date
Planned sale
Price
21.86
Quantity 4,400 -13.7%
Value US$96,184
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-09 2026-11-04 PlS Planned sale Non-Executive Director
21,664 +7.3%
425.85
US$3,218,696
21,664 +7.3% 425.85 US$3,218,696
2026-11-05 2026-11-03 PlS Planned sale Non-Executive Director
33,214 -5.1%
226.73
US$2,842,634
33,214 -5.1% 226.73 US$2,842,634
2026-11-03 2026-11-03 PrS Proposed sale

Director

Non-Executive Director
21,900
377.47
US$4,389,189
21,900 377.47 US$4,389,189
2026-08-20 2026-08-19 PrS Proposed sale

board of director

Non-Executive Director
15,000
36,017.33
US$540,260,000
15,000 36,017.33 US$540,260,000
2026-08-12 2026-08-10 S Sale

Chief Executive Officer

Executive Director
10,978 -4.5%
29.44
US$323,243
10,978 -4.5% 29.44 US$323,243
2026-08-10 2026-08-10 PrS Proposed sale

Officer; Director

Executive Director
10,978
29.44
US$323,243
10,978 29.44 US$323,243
2026-05-13 2026-05-11 S Sale

CHIEF FINANCIAL OFFICER

Officer
4,631 -3.4%
24.49
US$113,404
4,631 -3.4% 24.49 US$113,404
2026-05-11 2026-05-11 PrS Proposed sale

Officer

Officer
4,631
24.49
US$113,404
4,631 24.49 US$113,404
2026-02-25 2026-02-25 PrS Proposed sale

Officer

Officer
4,000
28.47
US$113,880
4,000 28.47 US$113,880
2026-02-26 2026-02-24 S Sale

Chief Executive Officer

Executive Director
10,993 -4.3%
28.94
US$318,144
10,993 -4.3% 28.94 US$318,144
2026-02-26 2026-02-24 S Sale

Sr. VP Mktg & Clinical Affairs

Officer
6,246 -7.0%
28.94
US$180,764
6,246 -7.0% 28.94 US$180,764
2026-02-26 2026-02-24 S Sale

CHIEF FINANCIAL OFFICER

Officer
7,701 -5.4%
28.94
US$222,880
7,701 -5.4% 28.94 US$222,880
2026-02-24 2026-02-24 PrS Proposed sale

Officer; Director

Executive Director
10,993
28.94
US$318,148
10,993 28.94 US$318,148
2026-02-24 2026-02-24 PrS Proposed sale

Officer

Officer
7,701
28.94
US$222,875
7,701 28.94 US$222,875
2026-02-24 2026-02-24 PrS Proposed sale

Officer

Officer
6,246
28.94
US$180,765
6,246 28.94 US$180,765
2026-02-24 2026-02-23 S Sale

CHIEF FINANCIAL OFFICER

Officer
196 -0.1%
28.69
US$5,623
196 -0.1% 28.69 US$5,623
2026-02-24 2026-02-23 S Sale

CHIEF FINANCIAL OFFICER

Officer
5,322 -3.6%
28.28
US$150,521
5,322 -3.6% 28.28 US$150,521
2026-02-24 2026-02-23 S Sale

Chief Executive Officer

Executive Director
537 -0.2%
28.69
US$15,406
537 -0.2% 28.69 US$15,406
2026-02-24 2026-02-23 S Sale

Chief Executive Officer

Executive Director
14,703 -5.4%
28.28
US$415,839
14,703 -5.4% 28.28 US$415,839
2026-02-24 2026-02-23 S Sale

Sr. VP Mktg & Clinical Affairs

Officer
160 -0.2%
28.69
US$4,590
160 -0.2% 28.69 US$4,590
2026-02-24 2026-02-23 S Sale

Sr. VP Mktg & Clinical Affairs

Officer
4,279 -4.6%
28.28
US$121,022
4,279 -4.6% 28.28 US$121,022
2026-02-23 2026-02-23 PrS Proposed sale

Officer

Officer
4,439
28.30
US$125,610
4,439 28.30 US$125,610
2026-02-23 2026-02-23 PrS Proposed sale

Officer; Director

Executive Director
15,240
28.30
US$431,246
15,240 28.30 US$431,246
2026-02-23 2026-02-23 PrS Proposed sale

Officer

Officer
5,518
28.30
US$156,143
5,518 28.30 US$156,143
2026-01-06 2026-01-02 PlS Planned sale

Sr. VP Mktg & Clinical Affairs

Officer
5,139 -6.6%
28.85
US$148,260
5,139 -6.6% 28.85 US$148,260
2026-01-02 2026-01-02 PrS Proposed sale

Officer

Officer
5,139
28.85
US$148,260
5,139 28.85 US$148,260
2025-08-12 2025-08-08 S Sale

Chief Executive Officer

Executive Director
7,762 -4.3%
12.36
US$95,907
7,762 -4.3% 12.36 US$95,907
2025-08-08 2025-08-08 PrS Proposed sale

Officer; Director

Executive Director
7,762
12.36
US$95,906
7,762 12.36 US$95,906
2025-05-14 2025-05-12 PlS Planned sale

Chief Financial Officer

Officer
2,921 -2.9%
9.94
US$29,037
2,921 -2.9% 9.94 US$29,037
2025-05-12 2025-05-12 PrS Proposed sale

Officer

Officer
2,921
9.94
US$29,037
2,921 9.94 US$29,037
2025-05-12 2025-05-08 S Sale

Chief Executive Officer

Executive Director
3,149 -1.7%
9.83
US$30,955
3,149 -1.7% 9.83 US$30,955
2025-05-09 2025-05-08 PlS Planned sale Non-Executive Director
3,300 -6.4%
9.67
US$31,911
3,300 -6.4% 9.67 US$31,911
2025-05-08 2025-05-08 PrS Proposed sale

Director

Non-Executive Director
3,149
9.83
US$30,955
3,149 9.83 US$30,955
2025-05-08 2025-05-08 PrS Proposed sale

Director

Non-Executive Director
3,300
9.67
US$31,911
3,300 9.67 US$31,911
2025-04-03 2025-04-03 PrS Proposed sale

Officer

Officer
2,355
13.14
US$30,945
2,355 13.14 US$30,945
2025-02-27 2025-02-25 PlS Planned sale Non-Executive Director
28,338 -11.7%
14.18
US$401,850
28,338 -11.7% 14.18 US$401,850
2025-02-27 2025-02-25 S Sale

Sr. VP Mktg & Clinical Affairs

Officer
6,468 -7.7%
14.40
US$93,160
6,468 -7.7% 14.40 US$93,160
2025-02-27 2025-02-25 PlS Planned sale

Chief Financial Officer

Officer
2,066 -2.0%
14.51
US$29,980
2,066 -2.0% 14.51 US$29,980
2025-02-25 2025-02-25 PrS Proposed sale

Officer

Officer
28,338
14.18
US$401,851
28,338 14.18 US$401,851
2025-02-25 2025-02-25 PrS Proposed sale

Officer

Officer
6,468
14.40
US$93,160
6,468 14.40 US$93,160
2025-02-25 2025-02-25 PrS Proposed sale

Officer

Officer
2,066
14.51
US$29,980
2,066 14.51 US$29,980
2025-02-24 2025-02-24 PrS Proposed sale

Officer

Officer
10,938
14.55
US$159,147
10,938 14.55 US$159,147
2025-02-24 2025-02-24 PrS Proposed sale

Officer

Officer
4,830
14.65
US$70,753
4,830 14.65 US$70,753
2025-02-24 2025-02-24 PrS Proposed sale

Officer

Officer
2,209
14.79
US$32,660
2,209 14.79 US$32,660
2025-02-24 2025-02-24 PrS Proposed sale

Officer

Officer
3,778
14.70
US$55,538
3,778 14.70 US$55,538
2025-02-24 2025-02-24 PlS Planned sale Non-Executive Director
10,938 -4.3%
14.55
US$159,147
10,938 -4.3% 14.55 US$159,147
2025-02-24 2025-02-24 PlS Planned sale

Chief Financial Officer

Officer
3,778 -3.5%
14.70
US$55,538
3,778 -3.5% 14.70 US$55,538
2025-02-24 2025-02-24 S Sale

Sr. VP Mktg & Clinical Affairs

Officer
4,830 -5.4%
14.65
US$70,753
4,830 -5.4% 14.65 US$70,753
2024-08-14 2024-08-12 S Sale

Senior VP, Sales

Officer
1,550 -3.8%
13.07
US$20,263
1,550 -3.8% 13.07 US$20,263
2024-08-12 2024-08-12 PrS Proposed sale

Officer

Officer
1,550
13.07
US$20,262
1,550 13.07 US$20,262
2024-05-20 2024-05-16 S Sale

Chief Financial Officer

Officer
3,041 -4.7%
13.68
US$41,590
3,041 -4.7% 13.68 US$41,590
2024-05-16 2024-05-16 PrS Proposed sale

Officer

Officer
3,041
13.68
US$41,590
3,041 13.68 US$41,590
2024-05-10 2024-05-08 PlS Planned sale Non-Executive Director
2,500 -9.0%
14.06
US$35,150
2,500 -9.0% 14.06 US$35,150
2024-05-08 2024-05-08 PrS Proposed sale

Director

Non-Executive Director
2,500
14.06
US$35,150
2,500 14.06 US$35,150
2024-05-08 2024-05-06 S Sale

Sr. VP Mktg & Clinical Affairs

Officer
815 -1.3%
14.37
US$11,713
815 -1.3% 14.37 US$11,713
2024-05-06 2024-05-06 PrS Proposed sale

Officer

Officer
815
14.37
US$11,713
815 14.37 US$11,713
2024-02-29 2024-02-29 PrS Proposed sale

Officer

Officer
1,396
15.25
US$21,289
1,396 15.25 US$21,289
2024-02-29 2024-02-29 PrS Proposed sale

Officer

Officer
243
15.25
US$3,706
243 15.25 US$3,706
2024-02-29 2024-02-29 PlS Planned sale

President and CEO

Executive Director
1,396 -0.6%
15.25
US$21,289
1,396 -0.6% 15.25 US$21,289
2024-02-29 2024-02-29 PlS Planned sale

Sr. VP Mktg & Clinical Affairs

Officer
243 -0.4%
15.25
US$3,706
243 -0.4% 15.25 US$3,706
2024-02-29 2024-02-27 PlS Planned sale

President and CEO

Executive Director
4,689 -1.9%
15.60
US$73,148
4,689 -1.9% 15.60 US$73,148
2024-02-29 2024-02-27 PlS Planned sale

Sr. VP Mktg & Clinical Affairs

Officer
1,091 -1.7%
15.58
US$17,001
1,091 -1.7% 15.58 US$17,001
2024-02-27 2024-02-27 PrS Proposed sale

Officer

Officer
4,689
15.60
US$73,148
4,689 15.60 US$73,148
2024-02-27 2024-02-27 PrS Proposed sale

Officer

Officer
1,091
15.58
US$17,001
1,091 15.58 US$17,001
2024-02-27 2024-02-26 PlS Planned sale

Sr. VP Mktg & Clinical Affairs

Officer
2,015 -3.1%
15.91
US$32,049
2,015 -3.1% 15.91 US$32,049
2024-02-27 2024-02-26 PlS Planned sale

President and CEO

Executive Director
6,239 -2.5%
15.81
US$98,645
6,239 -2.5% 15.81 US$98,645
2024-02-26 2024-02-26 PrS Proposed sale

Officer

Officer
6,239
15.81
US$98,645
6,239 15.81 US$98,645
2024-02-26 2024-02-26 PrS Proposed sale

Officer

Officer
2,015
15.91
US$32,049
2,015 15.91 US$32,049
2024-02-27 2024-02-23 PlS Planned sale

Sr. VP Mktg & Clinical Affairs

Officer
2,249 -4.0%
14.80
US$33,278
2,249 -4.0% 14.80 US$33,278
2024-02-27 2024-02-23 PlS Planned sale

President and CEO

Executive Director
5,378 -2.7%
14.85
US$79,853
5,378 -2.7% 14.85 US$79,853
2024-02-23 2024-02-23 PrS Proposed sale

Officer

Officer
2,249
14.80
US$33,278
2,249 14.80 US$33,278
2024-02-23 2024-02-23 PrS Proposed sale

Officer

Officer
5,378
14.85
US$79,853
5,378 14.85 US$79,853
2023-08-09 2023-08-07 S Sale

President and CEO

Executive Director
1,062 -0.8%
20.53
US$21,808
1,062 -0.8% 20.53 US$21,808
2023-08-07 2023-08-07 PrS Proposed sale

Officer; Director

Executive Director
1,062
20.53
US$21,808
1,062 20.53 US$21,808
2023-05-16 2023-05-12 PlS Planned sale Non-Executive Director
4,400 -13.7%
21.86
US$96,184
4,400 -13.7% 21.86 US$96,184

See older Tactile Systems Technology Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Tactile Systems Technology Inc history with Plus

Billed monthly · Cancel anytime